Argent Biopharma's market cap is currently $7.78M. The company's EPS TTM is AU$-0.079; its P/E ratio is ―; Argent Biopharma is scheduled to report earnings on August 28, 2025, and the estimated EPS forecast is AU$―. See an overview of income statement, balance sheet, and cash flow financials.
